10th 340B ADR Panel Ruling Again Rejects Provider Petition

HRSA 340B ADR Decision Summaries page
HRSA recently published the summary of the 10th 340B ADR decision under the agency's revamped process.
The 10th decision under HRSA’s 340B Administrative Dispute Resolution (ADR) once again sided with a drugmaker, marking another loss for [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

News Alert

Arkansas Sues 13 Drugmakers, Second Sight Over 340B Restrictions and Data Reqs

Arkansas Attorney General Tim Griffin (R) held a July 22 press conference with state 340B providers and advocates announcing a lawsuit against 13 drugmakers and Second Sight Solutions. (Photo courtesy of the Arkansas attorney general's office).
The Arkansas attorney general announced Wednesday that the state has filed what he predicted would become a “billion-dollar” lawsuit against [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

News Alert

Fed Appeals Court Upholds HHS Authority to Approve or Deny 340B Rebates

Washington, D.C. federal appeals court
A Washington, D.C. federal appeals court on July 21 found the 340B statute gives HHS the authority to approve or deny 340B rebate models.
A Washington, D.C. federal appeals court today upheld HHS’ authority to require drugmakers to seek approval before implementing 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

UNC Health, Humana Appear to Settle 340B Underpayment Lawsuits 

UNC Health
UNC Health on July 17 voluntarily dismissed two lawsuits alleging health insurer Humana had underpaid for certain 340B drugs.
A major North Carolina health system on Friday appeared to settle two lawsuits alleging health insurer Humana underpaid for 340B [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Hospital Groups Urge Fed Court to Dismiss AbbVie 340B Patient Definition Suit

AbbVie headquarters
Multiple hospital and pharmacist groups opposed drugmaker AbbVie's 340B patient definition lawsuit in a recently filed amicus brief.
Five major hospital and pharmacist groups on Tuesday urged a federal judge to reject drugmaker AbbVie’s lawsuit challenging HRSA’s longstanding [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

State Contract Pharmacy Lawsuit Roundup: Louisiana, Maryland, West Virginia and Washington

Courtroom gavel
Key updates occurred in litigation over 340B contract pharmacy access laws in Louisiana, Maryland, West Virginia and Washington.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

NACHC, RWC-340B Ask to Intervene in AbbVie 340B Patient Definition Suit

AbbVie
NACHC and RWC-340B recently asked to intervene in ongoing litigation to oppose drugmaker AbbVie's 340B patient definition lawsuit.
Two national 340B provider groups asked a federal judge Monday for permission to join HRSA in defending the agency’s 340B [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Longtime Drug Industry 340B Attorney Philip Perry Retires

Philip Perry
Philip Perry, who represented PhRMA in high-stakes 340B litigation as a partner at Latham & Watkins, recently retired. (Photo: Latham & Watkins bio)
Philip Perry, a longtime pharmaceutical industry attorney who has represented PhRMA and drug manufacturers in major 340B litigation, officially retired [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Florida Hospital Sues Lilly for Cutting Off 340B Pricing 

Tampa General Hospital
Tampa General Hospital recently sued Eli Lilly for cutting off 340B pricing over noncompliance with its new in-house pharmacy data requirements.
A Florida hospital recently sued Eli Lilly, alleging the pharmaceutical giant unlawfully cut off 340B pricing after the hospital refused [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »

Drugmakers Again Seek Dismissal of Hospital’s 340B Whistleblower Suit

Adventist health
Four drugmakers recently asked a California federal judge to dismiss Adventist Health System of West’s 340B whistleblower lawsuit.
Four major drugmakers recently renewed their push to dismiss a California health system’s 340B overcharge whistleblower lawsuit—just months after a [...]

Please Login or Become a Paid Subscriber to View this Content

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live